Raia Drogasil S.A.
RADLY
$3.18
$0.206.72%
| Weiss Ratings | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 6.52B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.12 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.65B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 39.05% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 55 11 3769 5678 | |||
| Address | Av. Corifeu de Azevedo Marques, 3.097 São Paulo, SP 05339-900 | |||
| Website | rdsaude.com.br | |||
| Country | Brazil | |||
| Year Founded | 1905 | |||
| Profitability | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.89% | |||
| Profit Margin | 3.05% | |||
| Management Effectiveness | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.90% | |||
| Return on Equity | 19.51% | |||
| Income Statement | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 7.22B | |||
| Total Revenue (TTM) | 7.22B | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 2.15B | |||
| EBITDA (TTM) | 557.56M | |||
| EBIT (TTM) | 426.22M | |||
| Net Income (TTM) | 220.60M | |||
| Net Income Avl. to Common (TTM) | 220.60M | |||
| Total Revenue Growth (Q YOY) | -4.29% | |||
| Earnings Growth (Q YOY) | 6.00% | |||
| EPS Diluted (TTM) | 0.12 | |||
| EPS Diluted Growth (Q YOY) | 17.59% | |||
| Balance Sheet | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 87.91M | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 2.05B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.04B | |||
| Current Ratio (Q) | 1.377 | |||
| Book Value Per Share (Q) | $0.61 | |||
| Total Assets (Q) | 3.58B | |||
| Total Current Liabilities (Q) | 1.49B | |||
| Total Debt (Q) | 1.24B | |||
| Total Liabilities (Q) | 2.54B | |||
| Total Common Equity (Q) | 1.04B | |||
| Cash Flow | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -257.19M | |||
| Cash from Financing (TTM) | -232.53M | |||
| Net Change in Cash (TTM) | 19.28M | |||
| Levered Free Cash Flow (TTM) | 287.73M | |||
| Cash from Operations (TTM) | 509.01M | |||
